Friday, May 12, 2017

Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 20 Issue 2

If you are unable to see the message below, click here to view.
Prostate Cancer and Prostatic Diseases

TABLE OF CONTENTS

Volume 20, Issue 2 (June 2017)

In this issue
Reviews
Original Articles
Letters to the Editor
Errata

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Follow PCAN on Twitter Twitter
Recommend to your library
Web feed
Subscribe
Advertisement
Celebrating 20 years of Prostate Cancer and Prostatic Diseases — 1997 to 2017

Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone. 

Watch our anniversary video showing a brief impact overview >>> 
 
 

Reviews

Top

Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review

M I Gökce, D Sundi, E Schaeffer and C Pettaway

Prostate Cancer Prostatic Dis 2017 20: 127-136; advance online publication, April 18, 2017; 10.1038/pcan.2016.56

Abstract | Full Text

Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update OPEN

P J Owen, R M Daly, P M Livingston and S F Fraser

Prostate Cancer Prostatic Dis 2017 20: 137-145; advance online publication, January 24, 2017; 10.1038/pcan.2016.69

Abstract | Full Text

Meta-analysis of metabolic syndrome and prostate cancer

M Gacci, G I Russo, C De Nunzio, A Sebastianelli, M Salvi, L Vignozzi, A Tubaro, G Morgia and S Serni

Prostate Cancer Prostatic Dis 2017 20: 146-155; advance online publication, February 21, 2017; 10.1038/pcan.2017.1

Abstract | Full Text

Original Articles

Top

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis

K Kuchta, Y Xiang, S Huang, Y Tang, X Peng, X Wang, Y Zhu, J Li, J Xu, Z Lin and T Pan

Prostate Cancer Prostatic Dis 2017 20: 156-164; advance online publication, February 14, 2017; 10.1038/pcan.2016.61

Abstract | Full Text

Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model

E H Allott, E Macias, S Sanders, B S Knudsen, G V Thomas, S D Hursting and S J Freedland

Prostate Cancer Prostatic Dis 2017 20: 165-171; advance online publication, February 28, 2017; 10.1038/pcan.2016.73

Abstract | Full Text

TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer

M K Siu, W-Y Chen, H-Y Tsai, H-Y Chen, J J Yin, C-L Chen, Y-C Tsai and Y-N Liu

Prostate Cancer Prostatic Dis 2017 20: 172-178; advance online publication, February 21, 2017; 10.1038/pcan.2017.2

Abstract | Full Text

The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy

M Maruf, M Fascelli, A K George, M M Siddiqui, M Kongnyuy, J M DiBianco, A Muthigi, S Valayil, A Sidana, T P Frye, A Kilchevsky, P L Choyke, B Turkbey, B J Wood and P A Pinto

Prostate Cancer Prostatic Dis 2017 20: 179-185; advance online publication, February 21, 2017; 10.1038/pcan.2016.46

Abstract | Full Text

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer OPEN

P L Nguyen, N E Martin, V Choeurng, B Palmer-Aronsten, T Kolisnik, C J Beard, P F Orio, M D Nezolosky, Y-W Chen, H Shin, E Davicioni and F Y Feng

Prostate Cancer Prostatic Dis 2017 20: 186-192; advance online publication, January 24, 2017; 10.1038/pcan.2016.58

Abstract | Full Text

Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease

J J Tosoian, R Alam, C Gergis, A Narang, N Radwan, S Robertson, T McNutt, A E Ross, D Y Song, T L DeWeese, P T Tran and P C Walsh

Prostate Cancer Prostatic Dis 2017 20: 193-196; advance online publication, January 3, 2017; 10.1038/pcan.2016.64

Abstract | Full Text

Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study

R Mathieu, M Moschini, B Beyer, K M Gust, T Seisen, A Briganti, P Karakiewicz, C Seitz, L Salomon, A de la Taille, M Rouprêt, M Graefen and S F Shariat

Prostate Cancer Prostatic Dis 2017 20: 197-202; advance online publication, January 10, 2017; 10.1038/pcan.2016.66

Abstract | Full Text

End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer

A K Narang, J Trieu, N Radwan, A Ram, S P Robertson, P He, C Gergis, E Griffith, H Singh, T A DeWeese, S Honig, A Annadanam, S Greco, C DeVille, T McNutt, T L DeWeese, D Y Song and P T Tran

Prostate Cancer Prostatic Dis 2017 20: 203-209; advance online publication, January 17, 2017; 10.1038/pcan.2016.67

Abstract | Full Text

Is prostate cancer stage migration continuing for black men in the PSA era?

R W Dobbs, D T Greenwald, H Wadhwa, V L Freeman and M R Abern

Prostate Cancer Prostatic Dis 2017 20: 210-215; advance online publication, January 17, 2017; 10.1038/pcan.2016.68

Abstract | Full Text

Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications

N Singla, J Walker, S L Woldu, N M Passoni, K de la Fuente and C G Roehrborn

Prostate Cancer Prostatic Dis 2017 20: 216-220; advance online publication, January 24, 2017; 10.1038/pcan.2016.70

Abstract | Full Text

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL OPEN

A H Bryce, J J Alumkal, A Armstrong, C S Higano, P Iversen, C N Sternberg, D Rathkopf, Y Loriot, J de Bono, B Tombal, S Abhyankar, P Lin, A Krivoshik, D Phung and T M Beer

Prostate Cancer Prostatic Dis 2017 20: 221-227; advance online publication, January 24, 2017; 10.1038/pcan.2016.71

Abstract | Full Text

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice

J J Tosoian, S C Druskin, D Andreas, P Mullane, M Chappidi, S Joo, K Ghabili, J Agostino, K J Macura, H B Carter, E M Schaeffer, A W Partin, L J Sokoll and A E Ross

Prostate Cancer Prostatic Dis 2017 20: 228-233; advance online publication, January 24, 2017; 10.1038/pcan.2016.72

Abstract | Full Text

The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer

S A Patel, M-H Chen, M Loffredo, A Renshaw, P W Kantoff and A V D'Amico

Prostate Cancer Prostatic Dis 2017 20: 234-240; advance online publication, January 24, 2017; 10.1038/pcan.2016.74

Abstract | Full Text

Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy

J V Hegde, D J Margolis, P-C Wang, R E Reiter, J Huang, M L Steinberg and M Kamrava

Prostate Cancer Prostatic Dis 2017 20: 241-248; advance online publication, January 31, 2017; 10.1038/pcan.2016.75

Abstract | Full Text

Letters to the Editor

Top

Reply to 'Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy'

M G Culha and O O Cakir

Prostate Cancer Prostatic Dis 2017 20: 249; advance online publication, April 11, 2017; 10.1038/pcan.2017.17

Full Text

Errata

Top

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis

K Kuchta, Y Xiang, S Huang, Y Tang, X Peng, X Wang, Y Zhu, J Li, J Xu, Z Lin and T Pan

Prostate Cancer Prostatic Dis 2017 20: 250; advance online publication, March 28, 2017; 10.1038/pcan.2017.11

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: